Angelini Pharma

We’re back with a new edition of our #FuturePills newsletter, your monthly roundup of positive news and insights from the world of science and medicine. In this issue, we look at new findings that deepen our understanding of brain health, from the biological roots of mental disorders to emerging tools for early diagnosis and prevention. We also explore how innovation, from genetics to AI, continues to shape the future of healthcare and well-being. Have a good read! 👀 #AngeliniPharma

#Autism and #epilepsy are clearly distinct conditions, yet research shows they can share physiological links: around 12% of individuals with autism also experience epileptic seizures. Early recognition of this overlap can be key in guiding treatment and improving patient outcomes. At Angelini Pharma, we are committed to raising awareness about these often-underrated challenges, supporting both healthcare professionals and families in understanding and managing the intersection of autism and epilepsy. Our latest article goes exactly in this direction: https://lnkd.in/dat3VrrF #AngeliniPharma #BrainHealth

An investment in mental health is an investment in Europe’s future. 🧠 On #WorldMentalHealthDay, our Chief Medical Officer Agnese Cattaneo reflects on the urgent need to strengthen Europe’s mental health systems, for individuals, communities, and economies alike. In the Headway Report 2024, we showed that investing in mental health delivers measurable economic returns. This year, we take the reflection one step further: true prosperity is not only about financial growth, but about the wellbeing of people, the strength of our communities, and the support we give each other. All essential elements for Europe to thrive. At the heart of this vision are #caregivers, whose invisible yet indispensable work sustains the very fabric of our societies. Read the article to discover why Europe cannot afford to neglect #mentalhealth— not in economic terms, and not in human ones. 👉https://lnkd.in/dQJm4b7C #AngeliniPharma The Pharma Letter

We’re back with a new edition of our #FuturePills newsletter, sharing positive updates from the world of pharmaceuticals and medicine. This month, we dive into promising advancements in the treatment of brain health conditions, ranging from Parkinson’s and Alzheimer’s to depression. We also explore timely topics, including the potential risks of AI on mental health and the greater burden of epilepsy on women. Enjoy the read! #AngeliniPharma

How much exercise is enough to make a difference? It’s a common question, and science gives us a clear answer: even moderate, consistent movement has measurable benefits for both body and mind. Regular physical activity is one of the most effective (and accessible) ways to strengthen overall well-being. It can lower the risk of depression and anxiety, support better sleep, and improve cardiovascular health. As the European Week of Sport comes to a close, let’s keep choosing to #BeActive together. https://lnkd.in/dMpTy76b #AngeliniPharma #EuropeanWeekOfSport 

Move more, scroll less. Because movement truly does wonders for your overall health.  With the European Week of Sport now in full swing, we want to take a moment to remind everyone that sport is not only about physical health and performance, but about the well-being of our brain and mind too. As a company that puts brain health at the forefront of our mission, we believe in spreading awareness about the scientifically proven benefits of movement on brain functions and mental health. You can read more on our website: https://lnkd.in/dMpTy76b   #AngeliniPharma #EuropeanWeekOfSport 

🔬 Tonight, we celebrate European Researchers’ Night, a unique occasion to bring science closer to people and celebrate research’s impact on our everyday lives. #Research is a continuous fuel to our mission at Angelini Pharma, and we firmly believe in the power of science to improve health and well-being. That’s why, today, we are proud to give space to the voices of our young researchers! 🎥 In this special vlog, three PhD students currently working at Angelini Pharma share a little bit of their daily life, showing what drives their passion for research and how their work contributes to innovation in healthcare.  Their stories remind us that behind every discovery there are people, curiosity, and commitment to making a difference. Let’s celebrate #research together! #AngeliniPharma #EuropeanResearchersNight 

Moving our bodies doesn’t just make us stronger, but it helps protect our brains too. It is well recognized and proven that even small amounts of #physicalactivity can positively impact our #mentalhealth: movement reduces the risk of depression, eases stress, lowers anxiety, and improves sleep quality. Over time, staying active consistently boosts overall well-being and supports mental health at every age. Our suggestion? From a simple walk to yoga or strength training, the best #sport is the one you enjoy, because that’s the one you’ll keep coming back to. 💙 https://lnkd.in/dMpTy76b #AngeliniPharma #EuropeanWeekOfSport 

The annual European Week of Sport starts today! 🎾🏊♀️⚽ From 23 to 30 September, we’re all invited to #BeActive together: an opportunity to get moving and acknowledge the physical, mental and social benefits of sport and physical activity. To celebrate, we asked three of our sporty colleagues to tell us a bit more about why they move in the way they do, and what real benefits they can see reflected in their bodies and minds. 🏃🧠 Laura shows us how sport enhances #brainhealth, Francesco delves into its #physicalhealth boost, and João proves that movement can support #selfcare and #wellbeing. In a world that sees most of us sitting at a computer for eight hours a day and looking at a phone screen for many others, this is our reminder to move more and scroll less. For a healthier life. Let’s get moving! #AngeliniPharma #EuropeanWeekOfSport 

Today, we take another step forward in our longtime commitment to #brainhealth. 🧠 We’re proud to announce an exclusive collaboration that further enhances our pipeline, with a special focus on rare epilepsies: joining forces with South-Korean biotechnology company Sovargen, we will be working to bring new therapeutic options to patients across the world suffering of a number of brain health disorders, including drug-resistant childhood epilepsy. Our commitment to #epilepsy has been strong and steady for years, and this new step brings us closer to our objective— addressing unmet needs in brain health and make a difference in people’s life. Thank you Sovargen for taking this step forward with us. Together, we turn science into care. https://lnkd.in/dkvQn2_j #AngeliniPharma